Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma.
Wijnands C, Karel PGA, Gloerich J, Armony G, Tzasta A, de Kat Angelino CM, Di Stefano L, Bonifay V, Luider TM, VanDuijn MM, Croockewit SJ, de Kort EA, Castelijn DAR, Stege CAM, Wessels HJCT, van Gool AJ, van de Donk NWCJ, Jacobs JFM. Wijnands C, et al. Among authors: bonifay v. Pharmaceutics. 2025 Jan 19;17(1):135. doi: 10.3390/pharmaceutics17010135. Pharmaceutics. 2025. PMID: 39861781 Free PMC article.
An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients.
Wijnands C, Armony G, Noori S, Gloerich J, Bonifay V, Caillon H, Luider TM, Brehmer S, Pfennig L, Srikumar T, Trede D, Kruppa G, Dejoie T, van Duijn MM, van Gool AJ, Jacobs JFM, Wessels HJCT. Wijnands C, et al. Among authors: bonifay v. Clin Chem Lab Med. 2024 Jun 17;62(12):2507-2518. doi: 10.1515/cclm-2024-0306. Print 2024 Nov 26. Clin Chem Lab Med. 2024. PMID: 38872409 Free article.
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.
Wijnands C, Langerhorst P, Noori S, Keizer-Garritsen J, Wessels HJCT, Gloerich J, Bonifay V, Caillon H, Luider TM, van Gool AJ, Dejoie T, VanDuijn MM, Jacobs JFM. Wijnands C, et al. Among authors: bonifay v. Clin Chem Lab Med. 2023 Oct 12;62(3):540-550. doi: 10.1515/cclm-2023-0781. Print 2024 Feb 26. Clin Chem Lab Med. 2023. PMID: 37823394 Free PMC article.
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.
Noori S, Wijnands C, Langerhorst P, Bonifay V, Stingl C, Touzeau C, Corre J, Perrot A, Moreau P, Caillon H, Luider TM, Dejoie T, Jacobs JFM, van Duijn MM. Noori S, et al. Among authors: bonifay v. Blood Cancer J. 2023 Feb 24;13(1):30. doi: 10.1038/s41408-023-00803-z. Blood Cancer J. 2023. PMID: 36828828 Free PMC article. No abstract available.
Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics.
Leus IV, Adamiak J, Chandar B, Bonifay V, Zhao S, Walker SS, Squadroni B, Balibar CJ, Kinarivala N, Standke LC, Voss HU, Tan DS, Rybenkov VV, Zgurskaya HI. Leus IV, et al. Among authors: bonifay v. Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0137722. doi: 10.1128/aac.01377-22. Epub 2023 Jan 30. Antimicrob Agents Chemother. 2023. PMID: 36715507 Free PMC article.
A selective antibiotic for Lyme disease.
Leimer N, Wu X, Imai Y, Morrissette M, Pitt N, Favre-Godal Q, Iinishi A, Jain S, Caboni M, Leus IV, Bonifay V, Niles S, Bargabos R, Ghiglieri M, Corsetti R, Krumpoch M, Fox G, Son S, Klepacki D, Polikanov YS, Freliech CA, McCarthy JE, Edmondson DG, Norris SJ, D'Onofrio A, Hu LT, Zgurskaya HI, Lewis K. Leimer N, et al. Among authors: bonifay v. Cell. 2021 Oct 14;184(21):5405-5418.e16. doi: 10.1016/j.cell.2021.09.011. Epub 2021 Oct 6. Cell. 2021. PMID: 34619078 Free PMC article.
22 results